IL92489A0 - Cloning and expression of simian transforming growth factor-beta 1 - Google Patents

Cloning and expression of simian transforming growth factor-beta 1

Info

Publication number
IL92489A0
IL92489A0 IL92489A IL9248989A IL92489A0 IL 92489 A0 IL92489 A0 IL 92489A0 IL 92489 A IL92489 A IL 92489A IL 9248989 A IL9248989 A IL 9248989A IL 92489 A0 IL92489 A0 IL 92489A0
Authority
IL
Israel
Prior art keywords
beta
tgf
cells
precursor
expression
Prior art date
Application number
IL92489A
Other languages
English (en)
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of IL92489A0 publication Critical patent/IL92489A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Control Of Eletrric Generators (AREA)
IL92489A 1988-12-16 1989-11-28 Cloning and expression of simian transforming growth factor-beta 1 IL92489A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28591788A 1988-12-16 1988-12-16
US35017189A 1989-04-17 1989-04-17
US35372889A 1989-05-17 1989-05-17

Publications (1)

Publication Number Publication Date
IL92489A0 true IL92489A0 (en) 1990-08-31

Family

ID=27403570

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92489A IL92489A0 (en) 1988-12-16 1989-11-28 Cloning and expression of simian transforming growth factor-beta 1

Country Status (16)

Country Link
EP (1) EP0373994B1 (xx)
JP (1) JPH03130089A (xx)
KR (1) KR900009985A (xx)
CN (1) CN1044125A (xx)
AT (1) ATE118546T1 (xx)
AU (1) AU638952B2 (xx)
CA (1) CA2003886A1 (xx)
DE (1) DE68921167T2 (xx)
DK (1) DK638989A (xx)
ES (1) ES2070924T3 (xx)
FI (1) FI895730A0 (xx)
IE (1) IE67811B1 (xx)
IL (1) IL92489A0 (xx)
NO (1) NO179676C (xx)
NZ (1) NZ231581A (xx)
PT (1) PT92454B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
US5304541A (en) * 1988-12-15 1994-04-19 Bristol-Myers Squibb Company Methods using novel chimeric transforming growth factor-β1/β2
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7141392B2 (en) 2001-01-09 2006-11-28 Queen Mary And Westfield College Latent fusion protein
GB0100551D0 (en) * 2001-01-09 2001-02-21 Queen Mary & Westfield College Protein
EP1279740A1 (en) * 2001-07-26 2003-01-29 Vrije Universiteit Brussel Recombinant vector derived from adeno-associated virus for gene therapy
WO2005068499A1 (en) * 2004-01-06 2005-07-28 The Government Of The United States As Representedby The Secretary, Department Of Health & Human Services Compositions and methods for the high efficiency expression of the transforming growth factor-beta supergene family
WO2012055541A1 (en) * 2010-10-25 2012-05-03 Bavarian Nordic A/S Tgf-beta in the development of conventional dendritic cells and uses thereof
CN104211778A (zh) * 2014-09-28 2014-12-17 苏州普罗达生物科技有限公司 一种转化生长因子β1激动剂多肽及其制备方法、应用
CN104311631A (zh) * 2014-09-28 2015-01-28 苏州普罗达生物科技有限公司 转化生长因子β1激动剂多肽及其制备方法、应用
RU2652312C2 (ru) * 2016-01-20 2018-04-25 Селл энд Джин Терапи Лтд Линейка биологически активных генно-терапевтических субстанций на основе гена tgfb1 для коррекции патологических состояний клеток органов и тканей и органов и тканей человека, способ получения и использования

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
CA2005120A1 (en) * 1988-12-15 1990-06-15 Anthony F. Purchio Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
FI901920A0 (fi) * 1989-04-20 1990-04-17 Lubrizol Corp Foerfaranden foer minskning av friktionen mellan i foerhaollande till varandra glidande komponenter genom anvaendning av metallkarboxylater.

Also Published As

Publication number Publication date
NO894759L (no) 1990-06-18
DK638989D0 (da) 1989-12-15
NO894759D0 (no) 1989-11-29
CN1044125A (zh) 1990-07-25
EP0373994B1 (en) 1995-02-15
IE67811B1 (en) 1996-05-01
NO179676B (no) 1996-08-19
DE68921167T2 (de) 1995-06-01
CA2003886A1 (en) 1990-06-16
ES2070924T3 (es) 1995-06-16
KR900009985A (ko) 1990-07-06
DK638989A (da) 1990-06-17
AU638952B2 (en) 1993-07-15
PT92454A (pt) 1990-06-29
PT92454B (pt) 1995-07-18
IE893779L (en) 1990-06-16
EP0373994A1 (en) 1990-06-20
NO179676C (no) 1996-11-27
ATE118546T1 (de) 1995-03-15
JPH03130089A (ja) 1991-06-03
DE68921167D1 (de) 1995-03-23
FI895730A0 (fi) 1989-11-29
AU4588289A (en) 1990-06-21
NZ231581A (en) 1993-01-27

Similar Documents

Publication Publication Date Title
EP0293785A3 (en) Cloning and expression of simian transforming growth factor-ss1
IL92489A0 (en) Cloning and expression of simian transforming growth factor-beta 1
GB8416356D0 (en) Microbially produced bgh
EP0357804A1 (en) Compositions containing modified erythropoietin
KR970703429A (ko) 동종 재조합에 영향을 주는 dna 구성물 및 이것의 사용 방법(dna construct for effecting homologous recombination and uses thereof)
EP1670918B1 (en) Leader sequences for use in production of proteins
GEP19970775B (en) Method for the production of human erythropoietin
EP1164195A3 (en) Adeno-associated virus with inverted terminal repeat sequences as promoter
ATE88501T1 (de) Rekombinante dns-expressionsvektoren.
EP1339855B1 (en) Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
JP2007300935A (ja) タンパク質を産生する能力を有し且つ無グルタミン培地中で成長する能力を有するグルタミン栄養要求性ヒト細胞
BR9905867A (pt) Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
Chung et al. Development of recombinant Chinese hamster ovary cell lines producing human thrombopoietin or its analog
EP0282512A4 (en) STABILIZATION OF MESSENGER RNA IN ANIMAL CELLS.
CA2295310A1 (en) Method for increasing secretion of proteins in eukaryotic host cells
Chen et al. Regulated secretion of prolactin by the mouse insulinoma cell line βTC-3
CA2297660A1 (en) Production of human mutated proteins in human cells by means of homologous recombination
IL174254A (en) Leader sequences for use in production of proteins